HETERO LABS LTD V FDA Approval ANDA 211065

ANDA 211065

HETERO LABS LTD V

FDA Drug Application

Application #211065

Application Sponsors

ANDA 211065HETERO LABS LTD V

Marketing Status

Over-the-counter001

Application Products

001TABLET;ORAL220MG0NAPROXEN SODIUMNAPROXEN SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2022-10-28STANDARD

Submissions Property Types

ORIG1Null7

CDER Filings

HETERO LABS LTD V
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211065
            [companyName] => HETERO LABS LTD V
            [docInserts] => ["",""]
            [products] => [{"drugName":"NAPROXEN SODIUM","activeIngredients":"NAPROXEN SODIUM","strength":"220MG","dosageForm":"TABLET;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/28\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-10-28
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.